Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18604002 | 1.00 | MAPT (0.32) | MAPT | |
| SCHEMBL6233428 | 1.00 | MAPT (0.32) | MAPT | |
| SCHEMBL17294092 | 1.00 | MAPT (0.32) | MAPT | |
| SCHEMBL4316497 | 0.77 | LMNA (0.34) | — | |
| SCHEMBL4316495 | 0.77 | LMNA (0.34) | — | |
| SCHEMBL4316502 | 0.77 | LMNA (0.34) | — | |
| SCHEMBL8764197 | 0.76 | — | — | |
| SCHEMBL1783162 | 0.75 | — | — | |
| SCHEMBL1782840 | 0.69 | CHRNB2 (0.30) | — | |
| SCHEMBL17627758 | 0.67 | TAS2R46 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4407019-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2024-07-31 | — | — | EP | claimed |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-05-30 | — | — | US | claimed |
| EP-4319715-A1 | FRAGRANCE COMPOSITION | Givaudan SA (CH) | 2024-02-14 | — | — | EP | claimed |
| WO-2022214636-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2022-10-13 | — | — | WO | claimed |
| US-11332693-B2 | Organic compounds | GIVAUDAN SA (CH) | 2022-05-17 | — | — | US | claimed |
| US-20180371359-A1 | Improvement In or Relating to Organic Compounds | GIVAUDAN SA (CH) | 2018-12-27 | — | — | US | claimed |
| US-20170073614-A1 | Perfume Compositions | GIVAUDAN SA (CH) | 2017-03-16 | — | — | US | claimed |
| EP-4549538-A2 | IMPROVEMENT IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2025-05-07 | — | — | EP | disclosed |
| EP-3387096-B1 | IMPROVEMENT IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-02-19 | — | — | EP | disclosed |
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | disclosed |
| EP-4407019-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2024-07-31 | — | — | EP | disclosed |
| EP-3429641-B1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2024-07-03 | — | — | EP | disclosed |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-05-30 | — | — | US | disclosed |
| US-9868923-B2 | Perfume compositions | GIVAUDAN S.A. (CH) | 2018-01-16 | — | — | US | disclosed |
| US-20170260476-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2017-09-14 | — | — | US | disclosed |
| US-20170073614-A1 | Perfume Compositions | GIVAUDAN SA (CH) | 2017-03-16 | — | — | US | disclosed |
| EP-0430315-B2 | Perfumed laundry detergents | QUEST INT (NL) | 2005-05-04 | — | — | EP | disclosed |
| US-6140295-A | PERFUMED LAUNDRY DETERGENT CONTAINING LIPASE AND THE MIXTURE OF FRAGRANCES SELECTED FROM AN ALIPHATIC AND CARBOCYCLIC KETONES, ALDEHYDES, NITRILES, CONDENSATION PRODUCT OF AMINES AND ALDEHYDE WITH MACROCYCLIC LACTONE MUSKS, AND FATTY ESTER | UNILEVER PATENT HOLDINGS B.V. (NL) | 2000-10-31 | — | — | US | disclosed |
| EP-0430315-B1 | Perfumed laundry detergents | UNILEVER NV (NL) | 1997-03-12 | — | — | EP | disclosed |
| EP-0430315-A2 | Perfumed laundry detergents | UNILEVER N.V. (NL) | 1991-06-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240173230-A1 | FRAGRANCE COMPOSITION | FABP2, FABP5, FAAH2 | MAPT 2375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.